Category: Alzheimer’s
-
Opinion: Everything is changing in dementia diagnosis and treatment
Opinion: Everything is changing in dementia diagnosis and treatment Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Jason Karlawish, who writes STAT’s Neurotransmissions column. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode…
-
STAT+: J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target
STAT+: J&J’s novel Alzheimer’s drug fails in key trial, dimming hopes for a hot target A promising Alzheimer’s disease treatment from Johnson & Johnson failed to slow the progress of the disease in a closely watched study, news that could dampen enthusiasm for a new class of potential medicines. J&J terminated its mid-stage study of…
-
Lithium, a treatment for bipolar disorders, might be a key to Alzheimer’s disease
Lithium, a treatment for bipolar disorders, might be a key to Alzheimer’s disease A new study finds that the element lithium plays a crucial role in healthy brain function and suggests it could be used to treat Alzheimer’s disease. In a Nature study published on Wednesday, researchers found that the brain produces lithium, and that…
-
Major Alzheimer’s group says some blood tests may be used in place of brain scans for diagnosis
Major Alzheimer’s group says some blood tests may be used in place of brain scans for diagnosis A major Alzheimer’s disease medical group is recommending that specialists may use certain blood tests to help diagnose patients with cognitive impairment in lieu of more complex and invasive tests, a move that could lead more people to…
-
STAT+: Undruggable ‘disordered’ proteins become druggable with new AI techniques from David Baker
STAT+: Undruggable ‘disordered’ proteins become druggable with new AI techniques from David Baker For decades, structural biologists shoved what looked like shoddy data in the back of their closets, embarrassed. While attempting to gather the structures of proteins, they would sometimes find that all or at least a portion of the protein would just not…
-
STAT+: U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service
STAT+: U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service LONDON — A U.K. health agency reiterated on Thursday that the limited benefits of a pair of new Alzheimer’s drugs do not justify their high prices, meaning the medicines won’t be made available through the National Health Service. The…
-
Opinion: Bill Gates: I lost my father to Alzheimer’s. But I’m more optimistic than ever about fighting the disease
Opinion: Bill Gates: I lost my father to Alzheimer’s. But I’m more optimistic than ever about fighting the disease Father’s Day without my dad never gets easier. Although he is on my mind every day, I always find myself thinking about him even more often this time of year. My dad was a giant in…
-
STAT+: Senators push back on Trump’s proposed $18 billion NIH budget cut
STAT+: Senators push back on Trump’s proposed $18 billion NIH budget cut National Institutes of Health Director Jay Bhattacharya faced sharp questions on Tuesday from Republican and Democratic members of a Senate Appropriations subcommittee about the agency’s 2026 budget, with lawmakers struggling to reconcile his stated commitment to biomedical research with recent grant terminations, funding…
-
FDA clears first blood test for diagnosing Alzheimer’s
FDA clears first blood test for diagnosing Alzheimer’s The Food and Drug Administration approved on Friday the first blood test for diagnosing Alzheimer’s disease, opening up a quicker way for patients to get detected for the neurological condition and receive treatment. The test, developed by Japan-based Fujirebio Diagnostics, uses a blood sample to detect the…